Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.

Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, Marzolla V, Fabbri A, Zennaro MC, Fève B.

Endocrinology. 2011 Jan;152(1):113-25. doi: 10.1210/en.2010-0674. Epub 2010 Nov 17.

PMID:
21084448
2.

Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.

Armani A, Cinti F, Marzolla V, Morgan J, Cranston GA, Antelmi A, Carpinelli G, Canese R, Pagotto U, Quarta C, Malorni W, Matarrese P, Marconi M, Fabbri A, Rosano G, Cinti S, Young MJ, Caprio M.

FASEB J. 2014 Aug;28(8):3745-57. doi: 10.1096/fj.13-245415. Epub 2014 May 7.

3.

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.

Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E.

Ann N Y Acad Sci. 1995 Jun 12;761:311-35.

PMID:
7625729
4.

Conception and pharmacodynamic profile of drospirenone.

Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A.

Steroids. 2003 Nov;68(10-13):891-905.

PMID:
14667981
5.

The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.

Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH.

Contraception. 1996 Oct;54(4):243-51.

PMID:
8922878
6.

Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

Caprio M, Fève B, Claës A, Viengchareun S, Lombès M, Zennaro MC.

FASEB J. 2007 Jul;21(9):2185-94. Epub 2007 Mar 23.

PMID:
17384139
7.

Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.

Desarzens S, Liao WH, Mammi C, Caprio M, Faresse N.

PLoS One. 2014 Apr 4;9(4):e94127. doi: 10.1371/journal.pone.0094127. eCollection 2014.

8.

Drospirenone, a progestogen with antimineralocorticoid properties: a short review.

Oelkers W.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):255-61. Review.

PMID:
15134826
9.

Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.

Stankov MV, Schmidt RE, Behrens GM; German Competence Network HIV/AIDS.

Antimicrob Agents Chemother. 2008 Aug;52(8):2882-9. doi: 10.1128/AAC.01505-07. Epub 2008 May 12.

10.

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Turpin E, Muscat A, Vatier C, Chetrite G, Corruble E, Moldes M, Fève B.

Br J Pharmacol. 2013 Jan;168(1):139-50. doi: 10.1111/j.1476-5381.2012.02140.x.

11.

Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes.

Tiller G, Fischer-Posovszky P, Laumen H, Finck A, Skurk T, Keuper M, Brinkmann U, Wabitsch M, Link D, Hauner H.

Endocrinology. 2009 Dec;150(12):5373-83. doi: 10.1210/en.2009-0488. Epub 2009 Nov 3.

PMID:
19887572
12.
13.

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.

Muhn P, Krattenmacher R, Beier S, Elger W, Schillinger E.

Contraception. 1995 Feb;51(2):99-110.

PMID:
7750297
14.
15.

Novel genes of visceral adiposity: identification of mouse and human mesenteric estrogen-dependent adipose (MEDA)-4 gene and its adipogenic function.

Zhang H, Chen X, Sairam MR.

Endocrinology. 2012 Jun;153(6):2665-76. doi: 10.1210/en.2011-2008. Epub 2012 Apr 17.

PMID:
22510272
16.

In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes.

El Hadri K, Glorian M, Monsempes C, Dieudonné MN, Pecquery R, Giudicelli Y, Andreani M, Dugail I, Fève B.

J Biol Chem. 2004 Apr 9;279(15):15130-41. Epub 2004 Jan 13.

17.

Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.

Tao H, Aakula S, Abumrad NN, Hajri T.

Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E68-79. doi: 10.1152/ajpendo.00367.2009. Epub 2009 Oct 27.

18.

Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors.

Simoncini T, Fu XD, Caruso A, Garibaldi S, Baldacci C, Giretti MS, Mannella P, Flamini MI, Sanchez AM, Genazzani AR.

Hum Reprod. 2007 Aug;22(8):2325-34. Epub 2007 Jun 2.

PMID:
17545686
19.

Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes.

Yang J, Ren J, Song J, Liu F, Wu C, Wang X, Gong L, Li W, Xiao F, Yan F, Hou X, Chen L.

Int J Mol Med. 2013 Jun;31(6):1429-35. doi: 10.3892/ijmm.2013.1350. Epub 2013 Apr 15.

PMID:
23588664
20.

Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome.

Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, Tsai FY, Yeh SC, Ko YC.

Toxicol Appl Pharmacol. 2010 Jun 15;245(3):370-7. doi: 10.1016/j.taap.2010.04.008. Epub 2010 Apr 18.

PMID:
20406654

Supplemental Content

Support Center